Veristat Assists EndoCeutics with NDA Submission for Intravaginal Prasterone
Veristat announced that it has been recognized by Inc. Magazine as one of the Countries’ fastest-growing private companies.
SOUTHBOROUGH, MA – July 13, 2015 – Veristat, a full service Clinical Research Organization (CRO), announced today that it has completed the move of its corporate headquarters to Southborough, Massachusetts. As previously announced, the move was driven by Veristat’s rapid growth in response to the increased demand for full-service clinical research offerings by its pharmaceutical and biotechnology clients.
HOLLISTON, MA – June 15, 2015 – Veristat, a full service Clinical Research Organization (CRO), announced today that it has opened a new office in San Bruno, California. Located in the heart of the San Francisco Bay Area life sciences community, the office will house Veristat’s West Coast operations, and will provide a full range of clinical services to clients developing therapies in all areas of biotechnology, pharmaceuticals, diagnostics and medical devices.
Veristat will Move Corporate Headquarters to Southborough, MA This Summer
Cynthia Henderson is recognized as an NAPW VIP Woman of the Year for her outstanding leadership and commitment within her profession
Garden City, NY (PRWEB) March 17, 2015
For Immediate Release
September 10, 2013 - Veristat, a leading, Boston-based clinical research organization today announced its advisory role on the implementation of an adaptive enrichment trial design for Verastem, Inc. (NASDAQ: VSTM).
